Evidence map›Paper›PMID 35011717›Full record

ArticleCells2022

Pathologic Proteolytic Processing of N-Cadherin as a Marker of Human Fibrotic Disease.

Paul Durham Ferrell, Kristianne Michelle Oristian, Everett Cockrell, Salvatore Vincent Pizzo

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. A porcine model of acute rejection for cardiac transplantation.Frontiers in cardiovascular medicine · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Paul Durham FerrellDepartment of Pathology, Duke University Medical Center, Durham, NC 27710, USA.
Kristianne Michelle OristianDepartment of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA.ORCID 0000-0003-0298-7323
Everett CockrellDepartment of Pathology, Duke University Medical Center, Durham, NC 27710, USA.
Salvatore Vincent PizzoDepartment of Pathology, Duke University Medical Center, Durham, NC 27710, USA.
Duke Medical Center · US

Funding

Kaganov Research Initiative In Pulmonary Medicine and Engineering FY20 AwardNorth Carolina Biotechnology Center 2019-TEG-1505
6 · The paper itself

Abstract

Prior research has implicated the involvement of cell adhesion molecule N-cadherin in tissue fibrosis and remodeling. We hypothesize that anomalies in N-cadherin protein processing are involved in pathological fibrosis. Diseased tissues associated with fibrosis of the heart, lung, and liver were probed for the precursor form of N-cadherin, pro-N-cadherin (PNC), by immunohistochemistry and compared to healthy tissues. Myofibroblast cell lines were analyzed for cell surface pro-N-cadherin by flow cytometry and immunofluorescent microscopy. Soluble PNC products were immunoprecipitated from patient plasmas and an enzyme-linked immunoassay was developed for quantification. All fibrotic tissues examined show aberrant PNC localization. Cell surface PNC is expressed in myofibroblast cell lines isolated from cardiomyopathy and idiopathic pulmonary fibrosis but not on myofibroblasts isolated from healthy tissues. PNC is elevated in the plasma of patients with cardiomyopathy (

Indexed as

AnimalsCadherinsCell DifferentiationFemaleFibrosisHumansMiceProteolysisCadherinscirrhosisfibronectinfibrosisheart failuremyofibroblastsN-cadherinpro-N-cadherinpulmonary fibrosis

Identifiers

PMID35011717
PMCPMC8750447
OpenAlexW4206404001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.